Wednesday, August 06, 2008

Which Drugmaker Will Be Biggest in 2014? Hint: Not Pfizer

File this under food for thought. I hope this helps stimulate some good investment ideas.
clipped from blogs.wsj.com
The drug industry’s about to plunge off a patent cliff, as blockbuster after blockbuster faces generic competition. But some companies are facing a steeper cliff than others.
Evaluate Pharma, a data crunching outfit based in London, pooled consensus forecasts to estimate how things will look in 2014.

Here’s a list of the top six, based on projected worldwide sales of prescription and over-the-counter drugs in 2014:

2014 RANKCOMPANY2007 RANK2014 DRUG SALES (EST., $m)
1Roche549,500
2Sanofi-Aventis348,011
3GlaxoSmithKline243,300
4Novartis442,875
5Johnson & Johnson732,547
6Pfizer129,287
 blog it

No comments:

Post a Comment